VerifyNow P2Y12 Parameters in Non-Drug Users

被引:0
|
作者
Lee, Young Kyung [1 ]
机构
[1] Hallym Univ, Coll Med, Anyang, Gyeonggido, South Korea
关键词
D O I
10.1093/ajcp/138.suppl2.124
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
342
引用
收藏
页码:A342 / A342
页数:1
相关论文
共 50 条
  • [1] Hirudin anticoagulation allows more rapid determination of P2Y12 inhibition by the VerifyNow P2Y12 assay
    Sumaya, Wael
    Daly, Rebecca L.
    Mehra, Sonal
    Dhutia, Amrita J.
    Howgego, Kate E.
    Ecob, Rosemary
    Judge, Heather M.
    Morton, Allison C.
    Storey, Robert F.
    THROMBOSIS AND HAEMOSTASIS, 2013, 109 (03) : 550 - 555
  • [2] Modification of the VerifyNow® P2Y12 test BASE channel to accommodate high levels of P2Y12 antagonism
    Jakubowski, Joseph A.
    Zhou, Chunmei
    Egan, Blaine
    Wells, Maggie
    Kotob-Yahfoufi, Maya
    Sugidachi, Atsuhiro
    Dahlen, Jeffrey R.
    PLATELETS, 2011, 22 (08) : 619 - 625
  • [3] Analysis of VerifyNow P2Y12 testing at an urban hospital system
    Oliphant, Carrie
    Covert, Ashley
    Van Berkel, Megan
    Hutchison, Lydia
    Swiggart, Cortney
    PHARMACOTHERAPY, 2017, 37 (12): : E144 - E144
  • [4] Effect of fibrinogen on platelet reactivity measured by the VerifyNow P2Y12 assay
    Dobrovolsky, A. B.
    Laguta, P. S.
    Guskova, E. V.
    Yarovaya, E. B.
    Titaeva, E. V.
    Storozhilova, A. N.
    Panchenko, E. P.
    BIOCHEMISTRY-MOSCOW, 2016, 81 (05) : 439 - 444
  • [5] Effect of fibrinogen on platelet reactivity measured by the VerifyNow P2Y12 assay
    A. B. Dobrovolsky
    P. S. Laguta
    E. V. Guskova
    E. B. Yarovaya
    E. V. Titaeva
    A. N. Storozhilova
    E. P. Panchenko
    Biochemistry (Moscow), 2016, 81 : 439 - 444
  • [6] Assessment of P2Y12 inhibition with the point-of-care device VerifyNow P2Y12 in patients treated with prasugrel or clopidogrel coadministered with aspirin
    Varenhorst, Christoph
    James, Stefan
    Erlinge, David
    Braun, Oscar O.
    Brandt, John T.
    Winters, Kenneth J.
    Jakubowski, Joseph A.
    Olofsson, Sylvia
    Wallentin, Lars
    Slegbahn, Agneta
    AMERICAN HEART JOURNAL, 2009, 157 (03) : 562.e1 - 562.e9
  • [7] Does Hemodialysis Affect Clopidogrel Resistance as Measured by VerifyNow® P2Y12 Test?
    Geara, Abdallah S.
    Ayoub, Isabelle
    Rached, Jacques Abi
    Siddique, Muhammad N.
    Ghimire, Pratima
    El-Sayegh, Suzanne
    AMERICAN JOURNAL OF CARDIOLOGY, 2011, 107 (07): : 1103 - 1104
  • [8] VerifyNow® P2Y12 assay for thienopyridine resistance: Single-centre experience
    Francisco, A. R.
    Patel, R. K.
    Melikian, N.
    Byrne, J.
    Roberts, L. N.
    Chitongo, P.
    Ford, E.
    Arya, R.
    BRITISH JOURNAL OF HAEMATOLOGY, 2010, 149 : 29 - 29
  • [9] CANGRELOR DOSE ADJUSTMENTS AND IMPACT ON P2Y12 VERIFYNOW AND THROMBOELASTOGRAPHY MAXIMUM AMPLITUDE
    Feih, Joel
    Kellicut, Megan
    Duewell, Brittney
    Martin, Trent
    Juul, Janelle
    CRITICAL CARE MEDICINE, 2024, 52
  • [10] Are P2Y12 reaction unit (PRU) and % inhibition index equivalent for the expression of P2Y12 inhibition by the VerifyNow® assay? Role of haematocrit and haemoglobin levels
    Voisin, Sophie
    Bongard, Vanina
    Tidjane, Mohammed A.
    Lhermusier, Thibault
    Carrie, Didier
    Sie, Pierre
    THROMBOSIS AND HAEMOSTASIS, 2011, 106 (02) : 227 - 229